STATE STREET CORP - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 134 filers reported holding VIKING THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$70,970,456
-9.2%
6,411,062
+33.0%
0.00%0.0%
Q2 2023$78,122,085
-11.2%
4,819,376
-8.7%
0.00%
-20.0%
Q1 2023$87,927,718
+1794.7%
5,280,944
+969.7%
0.01%
Q4 2022$4,640,630
+591.6%
493,684
+100.0%
0.00%
Q3 2022$671,000
-11.0%
246,842
-5.4%
0.00%
Q2 2022$754,000
-81.5%
261,042
-80.8%
0.00%
Q1 2022$4,072,000
-78.5%
1,357,176
-67.1%
0.00%
-100.0%
Q4 2021$18,978,000
-25.2%
4,125,567
+2.1%
0.00%0.0%
Q3 2021$25,385,000
-15.0%
4,042,251
-18.9%
0.00%
-50.0%
Q2 2021$29,866,000
-30.4%
4,985,960
-26.5%
0.00%0.0%
Q1 2021$42,912,000
+50.3%
6,784,444
+33.7%
0.00%0.0%
Q4 2020$28,558,000
-3.0%
5,072,556
+0.3%
0.00%0.0%
Q3 2020$29,439,000
-4.5%
5,058,164
+18.3%
0.00%0.0%
Q2 2020$30,835,000
+80.9%
4,276,762
+17.4%
0.00%
+100.0%
Q1 2020$17,044,000
-41.1%
3,641,950
+0.9%
0.00%
-50.0%
Q4 2019$28,954,000
+9.0%
3,610,262
-6.5%
0.00%0.0%
Q3 2019$26,563,000
-53.8%
3,860,870
-44.3%
0.00%
-50.0%
Q2 2019$57,539,000
-19.9%
6,932,425
-4.1%
0.00%
-33.3%
Q1 2019$71,845,000
+38.9%
7,227,888
+6.9%
0.01%
+20.0%
Q4 2018$51,725,000
-50.9%
6,761,485
+11.7%
0.01%
-37.5%
Q3 2018$105,451,000
+1418.8%
6,053,551
+727.5%
0.01%
+700.0%
Q2 2018$6,943,000
+4859.3%
731,568
+2193.3%
0.00%
Q1 2018$140,00031,9000.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders